Project Grant R01CA297832

Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $1.1M
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
New Brunswick, NJ 08901, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to Emory University for $140,511 supports the development of a computational framework that leverages AI visual explanation to guide AI-based abdominal cancer diagnostic imaging. The key objectives are to: 1) Improve AI sample efficiency through visual explanation supervision of cancer imaging annotations, 2) Consolidate AI's knowledge across multi-institutional data while...
This $700,611 Project Grant, awarded on March 11, 2025 by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a practical randomized controlled trial (RCT) of artificial intelligence (AI) for melanoma diagnosis at Memorial Sloan Kettering Cancer Center (MSK) and Stanford University (SU). The goal is to determine the potential benefits and barriers to clinical adoption of AI-assisted dermoscopy, and to evaluate the impact on the...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded a $693,156 Project Grant (CFDA 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health) to the Dana-Farber Cancer Institute, Inc. (DFCI) to develop artificial intelligence (AI) algorithms for predicting prognosis and optimizing treatment selection for cutaneous squamous cell carcinoma (CSCC), a highly prevalent form of skin cancer. The project aims to train and validate AI...
This National Cancer Institute (CFDA 93.394 Cancer Detection and Diagnosis Research) Project Grant award of $683,089 to the Sloan-Kettering Institute for Cancer Research supports the development of an improved, interpretable deep learning algorithm called DeepLIIF for more reproducible and accurate PD-L1 immunohistochemistry (IHC) biomarker quantification. The goal is to leverage virtual multiplex immunofluorescence (MPIF) restaining and large, diverse datasets across lung and bladder cancers to...
This Project Grant award of $499,997.00 from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program supports the development of a new framework to improve the interpretability and steerability of domain-specific AI models in medical imaging. The key products and services to be delivered include: Constructing an anatomically aware vision-language model capable of encoding and generating 3D medical images and radiology reports, to reduce the risk of...
This federal Project Grant award of $680,433 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to The Regents of the University of California, San Francisco (UCSF) aims to apply advanced spatial proteogenomic and artificial intelligence technologies to improve prognostic estimation and understand the underlying biology driving pathology AI algorithms for prostate cancer. The key objectives are to: 1) explore the relationships between standard-of-care...
This $591,606 Project Grant, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports research to optimize human-computer interaction in pathology and understand the impact of computer-aided diagnosis (CAD) tools on pathologists' interpretive performance. The project, led by the University of California, Los Angeles (UCLA), will randomize 250 pathologists to evaluate the effects of different types and timing of CAD cues on...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $406,204 to DePaul University to develop and validate a novel model of visual-semantic processing for computer-aided diagnosis (CAD) systems. The goal is to create explainable and accurate CAD mechanisms that establish a common understanding of visually important patterns for radiologists. The research involves developing a semantic deep-learning neural network (SDNN) that...
This federal Project Grant award of $402,728 from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop innovative interpretable deep learning models for multi-modality imaging in cancer prognostic assessment, with a focus on improving the accuracy and interpretability of prognosis predictions for gastric cancer patients. The funded research project at Wake Forest University Health Sciences will integrate domain knowledge from physician...
This $593,383 Project Grant, awarded by the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394), is supporting the development of an AI-augmented, multimodal, label-free nonlinear optical microscopy system for rapid and precise diagnosis of thyroid cancer and lymph node metastasis. The primary awardee, The Methodist Hospital Research Institute, is collaborating with The Johns Hopkins University on this project. The proposed system aims to eliminate...

SCH: COUNTERFACTUAL EXPLANATIONS FOR AI-ASSISTED CANCER DIAGNOSIS AND SUBTYPIING - ACCURATE DIAGNOSIS OF CANCER HINGES ON HISTOPATHOLOGICAL ASSESSMENT, WITH TREATMENT PIVOTING UPON THE TUMOR'S MORPHOLOGICAL CLASSIFICATION. AI MODELS, ESPECIALLY DEEP LEARNING (DL) MODELS, HAVE SHOWN GREAT PROMISE IN ACCURATELY CLASSIFYING TUMORS FROM HISTOPATHOLOGICAL IMAGES (OFTEN WITH ADDITIONAL GENOMIC INFORMATION). UNLIKE TYPICAL MEDICAL IMAGES FEATURING SMALL CRITICAL AREAS, HISTOPATHOLOGICAL IMAGES ARE TEXTURAL, WITH RELEVANT TEXTURE SPANNING THE ENTIRE IMAGE, MAKING IT CHALLENGING TO EXPLAIN DL PREDICTION BY LOCATING AREAS OF AN IMAGE. SUCH LACK OF EXPLAINABILITY (AND INTERPRETABILITY) SEVERELY LIMITS DL'S POTENTIAL AS A VALUABLE TOOL TO PATHOLOGISTS. THUS, THERE IS A CRITICAL NEED TO SYSTEMATICALLY EXPLAIN DL HISTOPATHOLOGICAL MODELS, BEYOND MERE LOCALIZATION, TO SUBSTANTIALLY IMPROVE AI-ASSISTED CANCER DIAGNOSIS FOR PATHOLOGISTS. THIS PROJECT AIMS TO DEVELOP A PRINCIPLED FRAMEWORK TO SYSTEMATICALLY EXPLAIN DL HISTOPATHOLOGICAL MODELS USING COUNTERFACTUAL EXPLANATIONS. THE RATIONALE IS THAT WHILE TEXTURE FEATURES ARE NOT AMENABLE TO LOCALIZATION-BASED EXPLANATION METHODS, ONE CAN EXPLAIN THE MODEL BY ASKING COUNTERFACTUAL QUESTIONS SUCH AS "WHAT HISTOPATHOLOGICAL IMAGE COULD HAVE SHIFTED THE MODEL PREDICTION FROM NON-AGGRESSIVE TUMOR TO AGGRESSIVE TUMOR". SPECIFICALLY, THIS PROJECT CENTERS AROUND FOUR TASKS: (1) DATASET-LEVEL GENERATIVE EXPLANATION: DEVELOPING A DATASET-LEVEL "GENERATIVE EXPLAINER" FRAMEWORK TO EXPLAIN ANY GIVEN DL HISTOPATHOLOGICAL MODEL BY GENERATING A SPECTRUM OF HISTOPATHOLOGICAL IMAGES THAT CAN LEAD TO AN ASSOCIATED SPECTRUM OF DIFFERENT PREDICTIONS (E.G., FROM "NON-AGGRESSIVE" THROUGH "AGGRESSIVE" TO "HIGHLY AGGRESSIVE") OF THE EXPLAINED DL MODEL. (2) INSTANCE-LEVEL COUNTERFACTUAL EXPLANATION: DEVELOPING A PRINCIPLED INSTANCE-LEVEL "COUNTERFACTUAL EXPLAINER" FRAMEWORK TO GENERATE INSTANCE-SPECIFIC COUNTERFACTUAL EXPLANATIONS FOR A SPECIFIC HISTOPATHOLOGICAL IMAGE. (3) FAST COUNTERFACTUAL EXPLANATION: DEVELOPING A "FAST COUNTERFACTUAL EXPLAINER" FRAMEWORK TO ENABLE REAL-TIME GENERATION OF COUNTERFACTUAL HISTOPATHOLOGICAL IMAGES. (4) FROM EXPLANATION TO SUBTYPE DISCOVERY: DEVELOPING A "SUBTYPING COUNTERFACTUAL EXPLAINER" FRAMEWORK THAT GOES BEYOND EXPLANATION TO DISCOVER NOVEL CANCER SUBTYPES (OR PHENOTYPES). RELEVANCE (SEE INSTRUCTIONS): ACCURATE DIAGNOSIS OF CANCER HINGES ON HISTOPATHOLOGICAL ASSESSMENT, WITH TREATMENT PIVOTING UPON THE TUMOR'S MORPHOLOGICAL CLASSIFICATION. AI MODELS CAN OFTEN ACCURATELY CLASSIFY TUMORS FROM HISTOPATHOLOGICAL IMAGES, BUT THEIR LACK OF INTERPRETABILITY SEVERELY HINDERS THEIR DEPLOYMENT IN CLINICAL SCENARIOS. THIS PROJECT DEVELOPS A PRINCIPLED FRAMEWORK TO SYSTEMATICALLY EXPLAIN AI HISTOPATHOLOGICAL MODELS USING COUNTERFACTUAL EXPLANATIONS, THEREBY SUBSTANTIALLY IMPROVING AI-ASSISTED CANCER DIAGNOSIS FOR PATHOLOGISTS.

Posted 7/1/24